Brain Cancer News

Treatment Guidelines for Patients with Newly Diagnosed Glioblastoma Multiforme (10/01/2008)
For the first time ever, the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors has issued treatment guidelines for patients with newly diagnosed glioblastoma multiforme. The guidelines were published in the September issue of the Journal of Neuro-Oncology.

Cell Phone Use Does Not Increase Risk of Developing Meningioma Brain Cancer (09/26/2008)
Researchers from Finland, Denmark, the United Kingdom, Sweden, and Norway have reported that long-term data do not indicate an association between the use of cell phones and an increased risk of meningioma. The details of this study appeared in an early online publication in the International Journal of Epidemiology.

Rituxan® May Be Effective in Central Nervous System Lymphomas (09/11/2008)
Rituxan® (rituximab) may be effective in the treatment of lymphoma that affects the brain and spinal cord (central nervous system). These results were recently presented at the 2008 annual meeting of the American Society of Clinical Oncology.

Novel Vaccine May Improve Survival in Brain Cancer (06/05/2008)
An investigative vaccine known as CDX-110 may improve survival for patients with glioblastoma multiforme (GBM), a form of brain cancer. These results were recently presented at the 2008 annual meeting of the American Society of Clinical Oncology in Chicago, Illinois.

Avastin® Improves Survival in Recurrent Brain Cancer (06/04/2008)
Patients with recurrent glioblastoma (a form of brain cancer) who were treated with Avastin® (bevacizumab) alone experienced a slight survival advantage compared with patients treated with Avastin plus Camptosar® (irinotecan). These results were presented at the 2008 annual meeting of the American Society of Clinical Oncology.

More...

General

Treatment Guidelines for Patients with Newly Diagnosed Glioblastoma Multiforme (10/01/2008)
For the first time ever, the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors has issued treatment guidelines for patients with newly diagnosed glioblastoma multiforme. The guidelines were published in the September issue of the Journal of Neuro-Oncology.

Cell Phone Use Does Not Increase Risk of Developing Meningioma Brain Cancer (09/26/2008)
Researchers from Finland, Denmark, the United Kingdom, Sweden, and Norway have reported that long-term data do not indicate an association between the use of cell phones and an increased risk of meningioma. The details of this study appeared in an early online publication in the International Journal of Epidemiology.

Rituxan® May Be Effective in Central Nervous System Lymphomas (09/11/2008)
Rituxan® (rituximab) may be effective in the treatment of lymphoma that affects the brain and spinal cord (central nervous system). These results were recently presented at the 2008 annual meeting of the American Society of Clinical Oncology.

Novel Vaccine May Improve Survival in Brain Cancer (06/05/2008)
An investigative vaccine known as CDX-110 may improve survival for patients with glioblastoma multiforme (GBM), a form of brain cancer. These results were recently presented at the 2008 annual meeting of the American Society of Clinical Oncology in Chicago, Illinois.

Avastin® Improves Survival in Recurrent Brain Cancer (06/04/2008)
Patients with recurrent glioblastoma (a form of brain cancer) who were treated with Avastin® (bevacizumab) alone experienced a slight survival advantage compared with patients treated with Avastin plus Camptosar® (irinotecan). These results were presented at the 2008 annual meeting of the American Society of Clinical Oncology.

More...